Monoethylglycinexylidide (Standard)
Monoethylglycinexylidide (Standard) is the analytical standard of Monoethylglycinexylidide (HY-118167). This product is intended for research and analytical applications. Monoethylglycinexylidide (MEGX; Norlidocaine) is the major metabolite of Lidocaine (HY-B0185), produced via oxidative metabolism by cytochrome P-450 enzymes in the liver. Monoethylglycinexylidide can be used for research on liver cirrhosis.
For research use only. We do not sell to patients.
- CAS No.: 7728-40-7
- Formula: C12H18N2O
- Molecular Weight:206.28
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 7728-40-7
-
Molecular Weight 206.28
-
Formula C12H18N2O
-
SMILES
O=C(CNCC)NC1=C(C=CC=C1C)C
-
Synonyms
MEGX (Standard); Norlidocaine (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Oni G, et al. Comparison of five commonly-available, lidocaine-containing topical anesthetics and their effect on serum levels of lidocaine and its metabolite monoethylglycinexylidide (MEGX). Aesthetic surgery journal. 2012 May;32(4):495-503. [Content Brief]
[2]. Elin RJ, et al. Assessment of monoethylglycinexylidide as measure of liver function for patients with chronic viral hepatitis. Clinical chemistry. 1997 Oct;43(10):1952-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Monoethylglycinexylidide (Standard)
- 7728-40-7
- MEGX (Standard)
- Norlidocaine (Standard)
- Reference Standards
- Drug Metabolite
- chronic viral hepatitis
- genetic heterogeneity
- human serum
- cytochrome P-450-inducing medications
- face
- hepatic oxidative deethylation
- gender
- neck
- hepatic cytochrome P-450
- cirrhosis
- Inhibitor
- inhibitor
- inhibit